| 9982016 |
NPR-B agonists |
Frank Osterkamp, Heiko Hawlisch, Gerd Hummel, Tobias Knaute, Ulf Reimer +5 more |
2018-05-29 |
|
| 9822147 |
Methods of treating ophthalmic diseases using NPR-B agonists |
Iok-Hou Pang |
2017-11-21 |
|
| 9745344 |
NPR-B agonists |
Frank Osterkamp, Heiko Hawlisch, Gerd Hummel, Tobias Knaute, Ulf Reimer +5 more |
2017-08-29 |
|
| 9458198 |
Cyclic peptide-based NPR-B agonists |
Frank Osterkamp, Heiko Hawlisch, Gerd Hummel, Tobias Knaute, Ulf Reimer +5 more |
2016-10-04 |
|
| 9187468 |
Topical ocular analgesic agents |
Martha E. Gadd, Peter G. Klimko, Karen C. David, Kenneth C. Appell |
2015-11-17 |
$12,726,000 |
| 9187525 |
Methods of treating ophthalmic diseases using NPR-B agonists |
Iok-Hou Pang |
2015-11-17 |
|
| 9169293 |
NPR-B agonists |
Frank Osterkamp, Heiko Hawlisch, Gerd Hummel, Tobias Knaute, Ulf Reimer +5 more |
2015-10-27 |
|
| 8551938 |
NPR-B agonists |
Iok-Hou Pang |
2013-10-08 |
|
| 8546523 |
NPR-B agonists |
Frank Osterkamp, Heiko Hawlisch, Gerd Hummel, Tobias Knaute, Ulf Reimer +5 more |
2013-10-01 |
|
| 8252793 |
Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma |
Keith Combrink, Suchismita Mohapatra, Najam A. Sharif, Ganesh Prasanna, Iok-Hou Pang +3 more |
2012-08-28 |
|
| 8138205 |
Heteroarylalkoxy-substituted quinolone inhibitors of PDE4 |
Steven P. Govek, Clay Beauregard, Daniel A. Gamache, Stewart A. Noble, Andrew K. Shiau +2 more |
2012-03-20 |
|
| 8067405 |
Superoxide dismutase mimics for the treatment of ocular disorders and diseases |
Peter G. Klimko, Robert J. Collier |
2011-11-29 |
$28,127,000 |
| 8003635 |
Superoxide dismutase mimics for the treatment of ocular disorders and diseases |
Peter G. Klimko, Robert J. Collier |
2011-08-23 |
$9,245,000 |
| 7923471 |
Method of treating dry eye disorders and uveitis |
Peter G. Klimko, Daniel A. Gamache |
2011-04-12 |
|
| 7906512 |
3,6-substituted imidazol[1,2-b]pyridazine analogs for treating allergic and inflammatory diseases |
Steven T. Miller, Andrew Rusinko |
2011-03-15 |
$166,719,000 |
| 7879905 |
5,6,7-trihydroxyheptanoic acid and analogs for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses |
Peter G. Klimko, David P. Bingaman, Daniel A. Gamache |
2011-02-01 |
$36,923,000 |
| 7867999 |
Hydroxyamino- and amino-substituted pyridine analogs for treating rho kinase-mediated diseases and conditions |
Hwang-Hsing Chen, Najam A. Sharif |
2011-01-11 |
$77,665,000 |
| 7820670 |
6-aminoimidazo[1,2-b]pyridazine analogs as rho kinase inhibitors for the treatment of rho kinase-mediated diseases and conditions |
Hwang-Hsing Chen, Andrew Rusinko, Bryon Severns, Alan John Henderson, Cheng Guo +1 more |
2010-10-26 |
$105,041,000 |
| 7799778 |
5-substituted 2-aminopyridine analogs for treating allergic and inflammatory diseases |
Steven T. Miller, Andrew Rusinko |
2010-09-21 |
$75,861,000 |
| 7763619 |
Compounds with 5-HT1A activity useful for treating disorders of the outer retina |
Robert J. Collier, Michael A. Kapin, Thomas R. Dean |
2010-07-27 |
$55,706,000 |
| 7759333 |
Superoxide dismutase mimics for the treatment of ocular disorders and diseases |
Peter G. Klimko, Robert J. Collier |
2010-07-20 |
$39,974,000 |
| 7754706 |
Superoxide dismutase mimics for the treatment of ocular disorders and diseases |
Peter G. Klimko, Robert J. Collier |
2010-07-13 |
$207,888,000 |
| 7713975 |
3,6-substituted imidazol[1,2-b]pyridazine analogs for treating allergic and inflammatory diseases |
Steven T. Miller, Andrew Rusinko |
2010-05-11 |
$40,500,000 |
| 7655662 |
(Indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)-pyrazines for treating glaucoma and controlling intraocular pressure |
Najam A. Sharif, Jesse A. May, Andrew Rusinko, Hwang-Hsing Chen |
2010-02-02 |
$392,542,000 |
| 7598288 |
Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma |
Abbot F. Clark, Iok-Hou Pang, Peggy Hellberg, Loretta McNatt, Wan-Heng Wang |
2009-10-06 |
$522,752,000 |
